To include your compound in the COVID-19 Resource Center, submit it here.

BTA585: Phase IIa started

Aviragen (formerly Biota Pharmaceuticals Inc.) began a double-blind, placebo-controlled, U.K. Phase IIa

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE